Plant Comparison
Mugwort vs Meadowsweet
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Mugwort and Meadowsweet: they share 9 indicated uses (arthritis / joint pain, cancer (anticancer research), indigestion, …); 5 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Mugwort | Meadowsweet | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Indigestion | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Menstrual cramps | 1/10 | 1/10 | Comparable evidence |
| Muscle spasm | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Multiple undescribed and known sesquiterpenoids and triterpenoids isolated from the leaves, several with anti-inflammatory activity.
Volatile oil containing thujone and other monoterpenes; thujone content is the basis of the caution on prolonged internal use.
Antioxidant and anti-inflammatory flavonoid and coumarin constituents.
Historically the source of aspirin's chemical inspiration; provide the plant's analgesic and anti-inflammatory activity, buffered by co-occurring mucilage and tannins.
Antioxidant constituents contributing to the plant's anti-inflammatory and gastroprotective effects.
Contribute to astringency and the characteristic sweet almond-like fragrance.
Pharmacological Actions
Artemisia vulgaris (mugwort) extracts inhibit BCR/ABL and induce apoptosis, ferroptosis and necroptosis in chronic myeloid leukaemia and breast cancer cells (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
Artemisia vulgaris (mugwort) extracts inhibit BCR/ABL and induce apoptosis in chronic myeloid leukaemia cells (including imatinib-resistant), and trigger tumour-selective ferroptosis/necroptosis in breast cancer and leukaemia cells via lysosomal Ca2+ signalling (preclinical).
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from gastroprotective action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from gastroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
inferred from diuretic action
Safety, Cautions & Contraindications
Contains thujone; avoid high doses or prolonged use. Contraindicated in pregnancy (uterine stimulant and abortifacient). May cause allergic reactions in individuals sensitive to the Asteraceae family. Avoid in epilepsy. Not recommended for children.
Duke (2002) rates mugwort as + (use with caution) and notes abortifacient (score 1), emmenagogue, aperitif (score 1), and insecticide activities. Duke clearly flags mugwort as contraindicated in pregnancy due to well-documented abortifacient and uterotonic properties. Traditional use has been as a digestive bitter, and the plant contains volatile oils, sesquiterpene lactones, and flavonoids. Duke notes that the plant may cause allergic reactions in individuals sensitive to Asteraceae and warns against long-term use due to potential neurotoxicity from thujone-containing essential oil (Duke, 2002).
Generally safe in normal culinary and medicinal doses. Avoid in salicylate sensitivity or aspirin allergy. Not recommended for children with viral illnesses (Reye's syndrome risk, as with other salicylate-containing plants). Avoid during pregnancy and breastfeeding.
Duke (2002) rates meadowsweet as ++ and notes analgesic, antiulcer, antirheumatic, astringent, and anti-aggregant activities at the experimental level (score 1). The plant is historically significant as a precursor to aspirin — salicylate compounds in meadowsweet were originally used to derive acetylsalicylic acid. Unlike aspirin, meadowsweet's salicylates are combined with protective mucilaginous compounds that may reduce gastric irritation. Duke notes that individuals with aspirin (salicylate) sensitivity should avoid meadowsweet; the plant also has anticoagulant properties that may interact with blood-thinning medications (Duke, 2002).
External Ids
Botanical Description
Tall, aromatic perennial herb with deeply lobed, dark green leaves that are distinctively silvery-white and woolly beneath. Small, dull reddish-brown to yellowish flower heads are borne in dense, branched, leafy spikes. The reddish-brown, ridged stems and the leaf's contrasting silver underside are characteristic field marks.[3]
Tall, moisture-loving perennial herb with pinnately compound leaves, dark green above and whitish-downy beneath, the leaflets sharply toothed. Dense, fluffy, creamy-white flower clusters with a strong, sweet, almond-like fragrance are borne atop reddish, grooved stems.[1]
Habitat
A common plant of waste ground, roadsides, hedgerows and riverbanks; native to Europe, Asia and North Africa and widely naturalised in North America.[3]
Grows in damp meadows, marshes, riverbanks, ditches and wet woodland margins; native to Europe and temperate Asia, favouring moist, nutrient-rich ground.[1]
Harvesting
The flowering aerial parts (leaf and stem) are cut in summer as flowering begins and dried in a warm, shaded, airy place; the root can be dug in autumn.[3]
The flowering tops, leaf and stem are cut in summer as the flowers open, when the characteristic salicylate content is highest, and dried in a warm, shaded, airy place.[1]
Traditional Uses
Mugwort is a widely used traditional bitter digestive tonic and calming nervine, and has a long reputation as an emmenagogue for menstrual complaints (reflected in its traditional use to bring on delayed menstruation, which is also why it is contraindicated in pregnancy). It has also been burned as 'moxa' in East Asian moxibustion and used as an insect repellent ('sailor's tobacco').[3]
Meadowsweet is historically significant as the plant from which salicylic acid derivatives (the chemical basis of aspirin) were first isolated, and has long been used in European folk medicine as an anti-inflammatory, analgesic and gastroprotective remedy for feverish colds, rheumatic and joint pain, and digestive complaints such as acid reflux and indigestion - notably, its natural mucilage is thought to buffer the gastric irritation associated with isolated salicylates.[1, 4]
Preparations
Dried flower, leaf and stem infused in hot water as a traditional anti-inflammatory and digestive tea.
Tincture (1:5) of the dried aerial parts; single dose 2-4 ml, daily dose 6-12 ml per the EU herbal monograph. Educational reference only, not a prescription.
Concentrated extract studied in vitro and in vivo for anti-inflammatory and gastroprotective activity.
Dosage
Health Canada's NNHPD monograph gives 0.2-2.4 g of dried herb top, 3 times per day, for adults 18 years and older, with infusion and decoction among the accepted methods of preparation. Educational reference only, not a prescription.
The EU herbal monograph gives a single dose of 1.5-6 g of the comminuted herb as an infusion, for a daily dose of 2-18 g, in adults and elderly; a powdered herbal substance at 250-500 mg per dose (250-1500 mg daily) and a 1:5 tincture at 2-4 mL per dose (6-12 mL daily) are also listed. Contraindicated in hypersensitivity to salicylates. For rheumatic-type complaints, not to be used for more than 4 weeks. Not recommended under 18 years. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Liu, T., Chen, X., Hu, Y., Li, M., Wu, Y. et al (2022) 'Sesquiterpenoids and triterpenoids with anti-inflammatory effects from Artemisia vulgaris L', Phytochemistry, 204, pp. 113428. doi:10.1016/j.phytochem.2022.113428 Preclinical
https://doi.org/10.1016/j.phytochem.2022.113428 - Trinh, P.T.N., Truc, N.C., Danh, T.T., Trang, N.T.T., Le Hang, D.T. et al (2024) 'A study on the antioxidant, anti-inflammatory, and xanthine oxidase inhibitory activity of the Artemisia vulgaris L. extract and its fractions', Journal of Ethnopharmacology, 334, pp. 118519. doi:10.1016/j.jep.2024.118519 Preclinical
https://doi.org/10.1016/j.jep.2024.118519 - Abiri, R., Silva, A.L.M., de Mesquita, L.S.S., de Mesquita, J.W.C., Atabaki, N. et al (2018) 'Towards a better understanding of Artemisia vulgaris: Botany, phytochemistry, pharmacological and biotechnological potential', Food Research International, 109, pp. 403-415. doi:10.1016/j.foodres.2018.03.072 Traditional / reference
https://doi.org/10.1016/j.foodres.2018.03.072 - Ekiert, H., Pajor, J., Klin, P., Rzepiela, A., Slesak, H. and Szopa, A (2020) 'Significance of Artemisia vulgaris L. (Common Mugwort) in the History of Medicine and Its Possible Contemporary Applications Substantiated by Phytochemical and Pharmacological Studies', Molecules, 25(19), pp. 4415. doi:10.3390/molecules25194415 Meta-analysis / review
https://doi.org/10.3390/molecules25194415 - Soon, L., Ng, P.Q., Chellian, J., Madheswaran, T., Panneerselvam, J., Gupta, G., Nammi, S., Hansbro, N.G., Hsu, A., Dureja, H., Mehta, M., Satija, S., Hansbro, P.M., Collet, T. and Chellappan, D.K (2019) 'Therapeutic potential of Artemisia vulgaris: An insight into underlying immunological mechanisms', Journal of Environmental Pathology, Toxicology and Oncology, 38(3), pp. 205-216. doi:10.1615/JEnvironPatholToxicolOncol.2019029397 Meta-analysis / review
https://doi.org/10.1615/JEnvironPatholToxicolOncol.2019029397 - Xiao, J., Liu, P., Hu, Y., Liu, T., Guo, Y., Sun, P., Zheng, J., Ren, Z. and Wang, Y (2023) 'Antiviral activities of Artemisia vulgaris L. extract against herpes simplex virus', Chinese Medicine, 18(1), pp. 21. doi:10.1186/s13020-023-00711-1 Preclinical
https://doi.org/10.1186/s13020-023-00711-1 - Singh, N.B., Devi, M.L., Biona, T., Sharma, N., Das, S., Chakravorty, J., Mukherjee, P.K. and Rajashekar, Y (2023) 'Phytochemical Composition and Antimicrobial Activity of Essential Oil from the Leaves of Artemisia vulgaris L', Molecules, 28(5), pp. 2279. doi:10.3390/molecules28052279 Preclinical
https://doi.org/10.3390/molecules28052279 - Judzentiene, A. and Budiene, J (2018) 'Chemical Polymorphism of Essential Oils of Artemisia vulgaris Growing Wild in Lithuania', Chemistry & Biodiversity, 15(2), pp. e1700257. doi:10.1002/cbdv.201700257 Preclinical
https://doi.org/10.1002/cbdv.201700257 - Hanh, T.T.H., Vinh, L.B., Cuong, N.X. and Quang, T.H (2022) 'Two new eudesmane sesquiterpene glucosides from the aerial parts of Artemisia vulgaris', Natural Product Research, 37(9), pp. 1544-1549. doi:10.1080/14786419.2022.2025591 Preclinical
https://doi.org/10.1080/14786419.2022.2025591 - Zamarioli, L.D.S., Santos, M.R.M., Erustes, A.G., Meccatti, V.M., Pereira, T.C., Smaili, S.S., Marcucci, M.C., Oliveira, C.R., Pereira, G.J.S. and Bincoletto, C (2023) 'Artemisia vulgaris Induces Tumor-Selective Ferroptosis and Necroptosis via Lysosomal Ca2+ Signaling', Chinese Journal of Integrative Medicine, 30(6), pp. 525-533. doi:10.1007/s11655-023-3712-2 Preclinical
https://doi.org/10.1007/s11655-023-3712-2 - Chi, H.T. and Ly, B.T.K (2022) 'Artemisia vulgaris inhibits BCR/ABL and promotes apoptosis in chronic myeloid leukemia cells', Biomedical Reports, 17(6), pp. 92. doi:10.3892/br.2022.1575 Preclinical
https://doi.org/10.3892/br.2022.1575 - Tiwari, R.K., Ahmad, A., Khan, A.F., Al-Keridis, L.A., Saeed, M., Alshammari, N., Alabdallah, N.M., Ansari, I.A. and Mujeeb, F (2023) 'Ethanolic Extract of Artemisia vulgaris Leaf Promotes Apoptotic Cell Death in Non-Small-Cell Lung Carcinoma A549 Cells through Inhibition of the Wnt Signaling Pathway', Metabolites, 13(4), pp. 480. doi:10.3390/metabo13040480 Preclinical
https://doi.org/10.3390/metabo13040480 - Health Canada, Natural and Non-prescription Health Products Directorate (2026) 'Natural Health Product Monograph: Mugwort - Artemisia vulgaris'. Available at: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_mugwort_english.pdf Traditional / reference
https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_mugwort_english.pdf - Becker, H (1986) 'Botany of European Artemisia species', pp. 1--24. Traditional / reference
https://scholar.google.com/scholar?q=Botany%20of%20European%20Artemisia%20species - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Kung, H.J. and Ko, W.C (2002) 'Pharmacological studies of Artemisia vulgaris', 13(2), pp. 99--108. Traditional / reference
https://scholar.google.com/scholar?q=Pharmacological%20studies%20of%20Artemisia%20vulgaris - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Totally Wild UK 'Mugwort (Artemisia vulgaris) Identification'. Available at: https://totallywilduk.co.uk/2021/04/13/identify-mugwort/ Traditional / reference
https://totallywilduk.co.uk/2021/04/13/identify-mugwort/ - Stetzenbach, M. and Schnorbus, B. and Sagoschen, I. and Bleser, W. and Legner, D. and Sturer, A (2017) 'Acute Monkshood Intoxication Requiring Acute Resuscitation', Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie, 52(9), pp. 641-644. doi:10.1055/s-0043-106283 Clinical study
https://doi.org/10.1055/s-0043-106283
- Samardžić, S., Arsenijević, J., Božić, D., Milenković, M. et al (2017) 'Antioxidant, anti-inflammatory and gastroprotective activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench', Journal of Ethnopharmacology, 213, pp. 132-137. doi:10.1016/j.jep.2017.11.013 Preclinical
https://doi.org/10.1016/j.jep.2017.11.013 - Andonova, T., Muhovski, Y., Apostolova, E., Naimov, S. et al (2024) 'DNA-Protective, Antioxidant and Anti-Carcinogenic Potential of Meadowsweet (Filipendula ulmaria) Dry Tincture', Antioxidants (Basel), 13(10), pp. 1200. doi:10.3390/antiox13101200 Preclinical
https://doi.org/10.3390/antiox13101200 - Van der Auwera, A., Peeters, L., Foubert, K., Piazza, S. et al (2023) 'In Vitro Biotransformation and Anti-Inflammatory Activity of Constituents and Metabolites of Filipendula ulmaria', Pharmaceutics, 15(4), pp. 1291. doi:10.3390/pharmaceutics15041291 Preclinical
https://doi.org/10.3390/pharmaceutics15041291 - Katanic, J., Boroja, T., Mihailovic, V., Nikles, S., Pan, S., Rosic, G., Selakovic, D., Joksimovic, J., Mitrovic, S. and Bauer, R (2016) 'In vitro and in vivo assessment of meadowsweet (Filipendula ulmaria) as anti-inflammatory agent', Journal of Ethnopharmacology, 193, pp. 627-636. doi:10.1016/j.jep.2016.10.015 Preclinical
https://doi.org/10.1016/j.jep.2016.10.015 - Samardzic, S., Tomic, M., Pecikoza, U., Stepanovic-Petrovic, R. and Maksimovic, Z (2016) 'Antihyperalgesic activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench in a rat model of inflammation', Journal of Ethnopharmacology, 193, pp. 652-656. doi:10.1016/j.jep.2016.10.024 Preclinical
https://doi.org/10.1016/j.jep.2016.10.024 - Katanic, J., Matic, S., Pferschy-Wenzig, E., Kretschmer, N., Boroja, T., Mihailovic, V., Stankovic, V., Stankovic, N., Mladenovic, M., Stanic, S., Mihailovic, M. and Bauer, R (2016) 'Filipendula ulmaria extracts attenuate cisplatin-induced liver and kidney oxidative stress in rats: In vivo investigation and LC-MS analysis', Food and Chemical Toxicology, 99, pp. 86-102. doi:10.1016/j.fct.2016.11.018 Preclinical
https://doi.org/10.1016/j.fct.2016.11.018 - Arsenijevic, N., Selakovic, D., Katanic Stankovic, J.S., Mihailovic, V., Mitrovic, S., Milenkovic, J., Milanovic, P., Vasovic, M., Nikezic, A., Milosevic-Djordjevic, O., Zivanovic, M., Filipovic, N., Jakovljevic, V., Jovicic, N. and Rosic, G (2021) 'Variable neuroprotective role of Filipendula ulmaria extract in rat hippocampus', Journal of Integrative Neuroscience, 20(4), pp. 871-883. doi:10.31083/j.jin2004089 Preclinical
https://doi.org/10.31083/j.jin2004089 - Matic, S., Katanic, J., Stanic, S., Mladenovic, M., Stankovic, N., Mihailovic, V. and Boroja, T (2015) 'In vitro and in vivo assessment of the genotoxicity and antigenotoxicity of the Filipendula hexapetala and Filipendula ulmaria methanol extracts', Journal of Ethnopharmacology, 174, pp. 287-292. doi:10.1016/j.jep.2015.08.025 Preclinical
https://doi.org/10.1016/j.jep.2015.08.025 - Pannakal, S.T., Eilstein, J., Hubert, J., Kotland, A., Prasad, A., Gueguiniat-Prevot, A., Juchaux, F., Beaumard, F., Seru, G., John, S. and Roy, D (2023) 'Rapid Chemical Profiling of Filipendula ulmaria Using CPC Fractionation, 2-D Mapping of 13C NMR Data, and High-Resolution LC-MS', Molecules, 28(17), pp. 6349. doi:10.3390/molecules28176349 Preclinical
https://doi.org/10.3390/molecules28176349 - Valle, M.G., Nano, G.M. and Tira, S (1988) 'The Essential Oil of Filipendula ulmaria', Planta Medica, 54(2), pp. 181-182. doi:10.1055/s-2006-962390 Preclinical
https://doi.org/10.1055/s-2006-962390 - Popowski, D., Zentek, J., Piwowarski, J.P. and Granica, S (2021) 'Gut Microbiota of Pigs Metabolizes Extracts of Filipendula ulmaria and Orthosiphon aristatus - Herbal Remedies Used in Urinary Tract Disorders', Planta Medica, 88(3-04), pp. 254-261. doi:10.1055/a-1647-2866 Preclinical
https://doi.org/10.1055/a-1647-2866 - Bespalov, V.G., Alexandrov, V.A., Semenov, A.L., Kovan'ko, E.G., Ivanov, S.D., Vysochina, G.I., Kostikova, V.A. and Baranenko, D.A (2016) 'The inhibitory effect of meadowsweet (Filipendula ulmaria) on radiation-induced carcinogenesis in rats', International Journal of Radiation Biology, 93(4), pp. 394-401. doi:10.1080/09553002.2016.1257834 Preclinical
https://doi.org/10.1080/09553002.2016.1257834 - European Medicines Agency (HMPC) (2011) 'Community herbal monograph on Filipendula ulmaria (L.) Maxim., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf - Bridge, J (2008) 'The Herbal Remedy Handbook'. Traditional / reference
https://scholar.google.com/scholar?q=The%20Herbal%20Remedy%20Handbook - Drummond, E.M., Harbourne, N., Marete, E., Jacquier, J.C., O'Riordan, D. and Gibney, E.R (2013) 'Inhibition of pro-inflammatory biomarkers in THP1 macrophages by polyphenols derived from chamomile, meadowsweet and willow bark', 27(4), pp. 588--594. Traditional / reference
https://scholar.google.com/scholar?q=Inhibition%20of%20pro-inflammatory%20biomarkers%20in%20THP1%20macrophages%20by%20polyphenols%20derived%20from%20chamomile%2C%20meadowsweet%20and%20willow%20bark - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.